Washington Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,650
Closed -$603K 116
2020
Q4
$603K Sell
7,650
-3,350
-30% -$196K 0.58% 53
2020
Q3
$483K Hold
11,000
0.5% 72
2020
Q2
$487K Buy
11,000
+3,500
+47% +$131K 0.54% 68
2020
Q1
$269K Buy
+7,500
New +$426K 0.34% 83

Other funds holding CMD

Washington Capital Management's CMD Position: Q1 2021 in Review

Washington Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 7,650 shares — an estimated $603K sold.

Washington Capital Management first reported a position in CMD in Q1 2020 and held it in 4 quarters. The position peaked at $603K in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Washington Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Washington Capital Management sold 7,650 Cantel Medical Corporation shares in Q1 2021, an estimated $603K.
  • Washington Capital Management first reported a position in Cantel Medical Corporation in Q1 2020 and held it in 4 quarters.
  • Washington Capital Management's Cantel Medical Corporation position peaked at $603K in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Washington Capital Management's 13F filing for Q1 2021, filed 4 May 2021.